Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer

Clinical trial NCT02188693 · UNKNOWN

Trial details

NCT number: NCT02188693
Sponsor: Xijing Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer Gemcitabine Maintenance Chemotherapy

Start date: 2014-07-01
Primary completion: 2017-07-01
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.